Folic acid supplementation rescues bladder injury in fetal rats with myelomeningocele

Abstract

AbstractBackgroundBladder dysfunction has been linked to the progression of renal failure in children with neurogenic bladder (NB) dysfunction. The purpose of this study was to determine whether bladder injuries in fetal rats with myelomeningocele (MMC) may be treated with folic acid.MethodsPregnant Sprague‐Dawley rats were randomly divided into three groups. On the 10th day of gestation, pregnant rats were intragastrically injected with all‐trans retinoic acid (ATRA) (60 mg/kg) to induce MMC fetal rats. The same amount of olive oil was put into the control group to create normal fetal rats. The rats in the rescue group were given folic acid (40 mg/kg) by gavage 0.5 and 12 hr after ATRA therapy. Bladders were obtained via cesarean section on embryonic day E20.5 and examined for MMC. The histology of the fetuses was examined using hematoxylin and eosin staining, and immunohistochemistry (IHC) was utilized to determine the expression of α‐smooth muscle actin (α‐SMA) and neuron‐specific nuclear‐binding protein (NeuN). Furthermore, the levels of neuromuscular development‐related and apoptotic proteins were determined by western blotting.ResultsThe incidence of MMC in the model group was 60.6% (20/33) while it was much lower in the rescue group (21.4%). In comparison to the model group, the weight and crown‐rump length of the fetal rats in the rescue group were significantly improved. IHC revealed that there was no significant difference in the expression of α‐SMA and NeuN between the control and ATRA groups, while the expression levels decreased significantly in the MMC group. Western blot analysis showed that there was no significant difference between the model and ATRA groups, but the expression of the α‐SMA protein and the β3‐tubulin was much lower in the MMC group than in the control group. After the administration of folic acid, the α‐SMA and β3‐tubulin proteins considerably increased in the folic acid‐rescued MMC group and folic acid‐rescued ATRA group. Meanwhile, in the control group, the expression of cleaved caspase‐3 in the bladder tissue was significantly higher, and the expression of poly (ADP‐ribose) polymerase (PARP) protein was significantly lower compared to the control group. Folic acid therapy reduced cleaved caspase‐3 expression while increasing PARP expression in comparison to the MMC group.ConclusionsNB in MMC fetal rats is associated with the reduction of bladder nerve and smooth muscle‐related protein synthesis. However, folic acid therapy can help improve these functional deficiencies. Folic acid also exhibits strong anti‐apoptotic properties against NB in MMC fetal rats.